Absci is an American biotechnology company that partners with pharmaceutical and biotechnology firms to develop protein-based drugs. By utilising deep learning AI and synthetic biology, the company seeks to broaden the therapeutic potential of proteins, offering unique solutions that integrate advanced technology in the drug development process.

Services include:
– Contract Manufacturing
– Cell Line Development
– Protein Production
– Process Development
– Analytical Services
– Formulation Development
– Quality Control
– Regulatory Support
– Clinical Supply Manufacturing

Through its innovative approach, Absci is positioned as a key supplier to the pharmaceutical industry, contributing significantly to the advancement of therapeutic proteins. For more information, please visit absci.com.